المؤلفون: Matera, Maria Gabriella, Rinaldi, Barbara, Belardo, Carmela, Calzetta, Luigino, Cazzola, Mario

المصدر: Expert Opinion on Drug Metabolism & Toxicology; June 2023, Vol. 19 Issue: 6 p345-355, 11p

المؤلفون: Calzetta, Luigino, Matera, Maria Gabriella, Rogliani, Paola

المصدر: Expert Opinion on Drug Metabolism & Toxicology; June 2019, Vol. 15 Issue: 6 p517-520, 4p

المؤلفون: Cazzola, Mario, Calzetta, Luigino, Matera, Maria Gabriella, Hanania, Nicola A, Rogliani, Paola

المصدر: Expert Opinion on Drug Metabolism & Toxicology; April 2018, Vol. 14 Issue: 4 p435-446, 12p

المؤلفون: Matera, Maria Gabriella, Rogliani, Paola, Calzetta, Luigino, Cazzola, Mario

المصدر: Expert Opinion on Drug Metabolism & Toxicology; February 2018, Vol. 14 Issue: 2 p239-245, 7p

المؤلفون: Matera, Maria Gabriella, Rinaldi, Barbara, Calzetta, Luigino, Cazzola, Mario

المصدر: Expert Opinion on Drug Metabolism & Toxicology; November 2017, Vol. 13 Issue: 11 p1159-1167, 9p

المؤلفون: Matera, Maria Gabriella, Calzetta, Luigino, Rinaldi, Barbara, Cazzola, Mario

المصدر: Expert Opinion on Drug Metabolism & Toxicology; September 2017, Vol. 13 Issue: 9 p1007-1013, 7p

المؤلفون: Matera, Maria Gabriella, Rinaldi, Barbara, Calzetta, Luigino, Cazzola, Mario

المصدر: Expert Opinion on Drug Metabolism & Toxicology; February 2017, Vol. 13 Issue: 2 p129-136, 8p

المؤلفون: Calzetta, Luigino, Rinaldi, Barbara, Cazzola, Mario, Matera, Maria Gabriella

المصدر: Expert Opinion on Drug Metabolism & Toxicology; July 2016, Vol. 12 Issue: 7 p813-822, 10p

المؤلفون: Cazzola, Mario, Calzetta, Luigino, Page, Clive P, Matera, Maria Gabriella

المصدر: Expert Opinion on Drug Metabolism & Toxicology; January 2014, Vol. 10 Issue: 1 p129-137, 9p

المؤلفون: Paola Rogliani, Luigino Calzetta, Mario Cazzola, Maria Gabriella Matera

المساهمون: Matera, Maria Gabriella, Rogliani, Paola, Calzetta, Luigino, Cazzola, Mario

المصدر: Expert Opinion on Drug Metabolism & Toxicology. 14:239-245

مصطلحات موضوعية: Settore MED/10 - Malattie dell'Apparato Respiratorio, Asthma, eosinophils, humanized monoclonal antibody, interleukin-5, reslizumab, Eosinophil, Antibodies, Monoclonal, Humanized, Toxicology, Severity of Illness Index, 03 medical and health sciences, Th2 Cells, 0302 clinical medicine, Reslizumab, medicine, Animals, Humans, Anti-Asthmatic Agent, Anti-Asthmatic Agents, 030212 general & internal medicine, Th2 Cell, Interleukin 5, Inflammation, Pharmacology, Animal, business.industry, Pharmacokinetic pharmacodynamic, Allergic asthma, General Medicine, respiratory system, medicine.disease, respiratory tract diseases, medicine.anatomical_structure, 030228 respiratory system, Immunology, business, Infiltration (medical), Human, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0730d03cc25578aa7a7020d31dca8a2Test
https://doi.org/10.1080/17425255.2018.1421170Test